Document is current
Any future updates will be listed below
-
Authors
Alsaadi, Taoufik https://orcid.org/0000-0002-7513-5706
Kayed, Deeb M.
Al-Madani, Abubaker
Hassan, Ali Mohamed
Terruzzi, Alessandro
Krieger, Derk
Riachi, Naji
Sarathchandran, Pournamy
Al-Rukn, Suhail
-
Funding
Funding for this research was provided by:
Novartis Pharmaceuticals Middle East
- License Information
-
More Information
Article History
Received: 9 August 2023
Accepted: 19 September 2023
First Online: 4 October 2023
Declarations
:
: Abubaker Al-Madani, Derk Krieger, Suhail Al-Rukn, Alessandro Terruzzi, and Ali Mohamed Hassan have received speaker and consultancy fees from Pfizer, Eli Lilly, Novartis, Lundbeck, and Abbvie. Taoufik Alsaadi and Naji Riachi have received research grants, as well as speaker and consultancy fees from Pfizer, Eli Lilly, Novartis, Lundbeck, and Abbvie. Deeb M. Kayed has received honoraria, travel support, speaker fees, and advisory board fees from Abbvie, Eli Lilly, Lundbeck, Novartis, and Pfizer. Pournamy Sarathchandran has no competing interest to declare.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
